Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Baxter
Fuji
McKinsey
Merck
Harvard Business School
Dow
Argus Health
Chinese Patent Office

Generated: January 16, 2018

DrugPatentWatch Database Preview

DIAL Drug Profile

« Back to Dashboard

When do Dial patents expire, and what generic alternatives are available?

Dial is a drug marketed by Dial and B Braun and is included in three NDAs.

The generic ingredient in DIAL is calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate. There are two hundred and seventy drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate profile page.

US Patents and Regulatory Information for DIAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dial DIAL hexachlorophene SOLUTION;TOPICAL 017421-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018460-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride SOLUTION;INTRAPERITONEAL 018807-002 Aug 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018460-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018460-005 Nov 2, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride SOLUTION;INTRAPERITONEAL 018460-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride SOLUTION;INTRAPERITONEAL 018807-001 Aug 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride SOLUTION;INTRAPERITONEAL 018807-003 Aug 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018460-007 Jan 29, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride SOLUTION;INTRAPERITONEAL 018807-004 Aug 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Express Scripts
Mallinckrodt
Covington
Julphar
Boehringer Ingelheim
Cerilliant
McKesson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot